United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market to Grow with a CAGR of 5.55% through 2030

Growing Burden of Cardiovascular Disorders and Technological Advancements are expected to drive the United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market growth in the forecast period, 2026-2030 

According to TechSci Research report, “United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market – By Region, Competition, Forecast & Opportunities, 2020-2030F”, the United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market stood at USD 3.70 Billion in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 5.55% through 2026-2030.

The United States Cardiac Monitoring & Cardiac Rhythm Management (CRM) Devices Market is experiencing sustained growth, driven by a combination of demographic, clinical, and technological factors that continue to reshape the cardiovascular care landscape. As the burden of heart disease increases and the U.S. population continues to age, the demand for sophisticated monitoring and rhythm management solutions is expanding rapidly.

A sharp rise in cardiovascular disease prevalence, particularly arrhythmias, heart failure, and coronary artery disease, has been a primary catalyst for market expansion. With an aging population more susceptible to cardiac complications, healthcare systems are under mounting pressure to adopt early intervention strategies, fueling demand for advanced CRM devices. Simultaneously, technological innovation is transforming the market. The development of miniaturized, user-friendly, and connected devices ranging from implantable loop recorders and mobile telemetry units to AI-powered ECG platforms and next-generation pacemakers has significantly enhanced clinical accuracy, patient compliance, and remote care capabilities. These innovations not only enable real-time monitoring and data-driven decision-making but also reduce hospital readmissions and overall cost of care.

The U.S. healthcare ecosystem’s strong reimbursement infrastructure, including support from Medicare and private insurers for remote patient monitoring and implantable cardiac devices, further incentivizes adoption. Hospitals and specialized cardiac clinics equipped with the necessary infrastructure and clinical expertise remain key distribution points for these technologies, contributing heavily to market volume. Moreover, rising healthcare expenditures, combined with strategic public and private investments in digital health infrastructure, are accelerating the integration of CRM solutions into mainstream care pathways. The push toward value-based care also reinforces the importance of continuous cardiac monitoring, timely diagnosis, and personalized treatment planning.

The U.S. market serves as a global benchmark for innovation and scalability in cardiac monitoring and rhythm management. Home to leading medtech companies, research institutions, and regulatory bodies, the region fosters a high degree of collaboration and rapid commercialization of new technologies. The market’s continued focus on data-driven, patient-centric solutions powered by wireless connectivity, AI algorithms, and cloud-based analytics positions it at the forefront of next-generation cardiovascular care.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market”

The United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market is segmented into product type, end user, regional distribution, and company.

Based on the End User, hospitals and clinics segment dominated the United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market. Hospitals and clinics serve as the primary centers for conducting a broad range of diagnostic and therapeutic cardiac procedures, including electrophysiology studies, pacemaker and defibrillator implantations, cardiac resynchronization therapy (CRT), and acute care monitoring. These facilities manage a significant portion of patients presenting with arrhythmias, heart failure, or post-cardiac surgery conditions, making them the largest consumers of CRM and cardiac monitoring devices.

Unlike ambulatory or home-care settings, hospitals and specialty cardiac clinics are equipped with advanced imaging, telemetry, catheterization labs, and surgical suites, enabling them to offer integrated care using a full spectrum of CRM and monitoring technologies. Devices such as multi-lead ECG machines, implantable loop recorders, Holter monitors, and ICDs are often deployed in combination for complex diagnosis and management, reinforcing the centrality of hospitals in the market. Hospitals are better positioned to navigate the complex reimbursement landscape for high-cost CRM devices, including implantable pacemakers, CRT-Ds, and remote telemetry systems. They also benefit from institutional coding and billing systems that support bundled payments and DRG (Diagnosis-Related Group) reimbursements for cardiac interventions providing them a financial edge in deploying these technologies at scale.

Major companies operating in the United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market are:

• Abbott Laboratories, Inc.
• Medtronic USA, Inc.
• Boston Scientific Corporation
• GE Healthcare
• Philips Healthcare (USA)
• Hill-Rom Holdings, Inc.
• BIOTRONIK, Inc.
• Alivecor, Inc.

Download Free Sample Report

Customers can also request 10% free customization on this report.

“The United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market is poised for significant growth in the future. This growth will be propelled by the increasing prevalence of cardiovascular diseases, driven in part by factors such as sedentary lifestyles, poor dietary habits, and genetic predispositions. With an aging population, the demand for cardiac monitoring and rhythm management devices is expected to rise, as older individuals are more susceptible to heart-related conditions. Technological advancements are also expected to contribute to market expansion. The development of innovative devices with improved accuracy, ease of use, and patient comfort will drive adoption rates. The United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market is set to experience significant growth in the coming years. Factors such as the rising prevalence of cardiovascular diseases, the aging population, and technological advancements will drive this growth. The integration of telecardiology, remote monitoring, AI, and ML will further enhance the capabilities of cardiac monitoring, revolutionizing the sector and improving patient care. However, addressing cost barriers and cybersecurity concerns will be essential to ensure the widespread adoption and success of these devices”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Product Type (Cardiac Monitoring Devices, Cardiac Rhythm Management Device), By End User (Hospitals & Clinics, Cardiac Care Centers, Ambulatory Surgery Centers, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com